179 related articles for article (PubMed ID: 35416977)
1. An animal model for Pierpont syndrome: a mouse bearing the Tbl1xr1Y446C/Y446C mutation.
Hu Y; Lauffer P; Stewart M; Codner G; Mayerl S; Heuer H; Ng L; Forrest D; van Trotsenburg P; Jongejan A; Fliers E; Hennekam R; Boelen A
Hum Mol Genet; 2022 Aug; 31(17):2951-2963. PubMed ID: 35416977
[TBL] [Abstract][Full Text] [Related]
2. The role of transducin β-like 1 X-linked receptor 1 (TBL1XR1) in thyroid hormone metabolism and action in mice.
Hu Y; Falize K; van Trotsenburg ASP; Hennekam R; Fliers E; Bruinstroop E; Boelen A
Eur Thyroid J; 2023 Oct; 12(5):. PubMed ID: 37458724
[TBL] [Abstract][Full Text] [Related]
3. A specific mutation in TBL1XR1 causes Pierpont syndrome.
Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
[TBL] [Abstract][Full Text] [Related]
4. Analysis of genes differentially expressed in the cortex of mice with the Tbl1xr1
Hu Y; Lauffer P; Jongejan A; Falize K; Bruinstroop E; van Trotsenburg P; Fliers E; Hennekam RC; Boelen A
Gene; 2024 Jun; 927():148707. PubMed ID: 38885822
[TBL] [Abstract][Full Text] [Related]
5. Pierpont syndrome associated with the p.Tyr446Cys missense mutation in TBL1XR1.
Slavotinek A; Pua H; Hodoglugil U; Abadie J; Shieh J; Van Ziffle J; Kvale M; Lee H; Kwok PY; Risch N; Sabbadini M
Eur J Med Genet; 2017 Oct; 60(10):504-508. PubMed ID: 28687524
[TBL] [Abstract][Full Text] [Related]
6. TBL1XR1 mutations in Pierpont syndrome are not restricted to the recurrent p.Tyr446Cys mutation.
Lemattre C; Thevenon J; Duffourd Y; Nambot S; Haquet E; Vuadelle B; Genevieve D; Sarda P; Bruel AL; Kuentz P; Wells CF; Faivre L; Willems M
Am J Med Genet A; 2018 Dec; 176(12):2813-2818. PubMed ID: 30365874
[TBL] [Abstract][Full Text] [Related]
7. A novel de novo pathogenic variant in TBL1XR1 as a new proposed cause of Pierpont syndrome.
Tamma PL; Streff H; Murali CN
Am J Med Genet A; 2023 Jun; 191(6):1576-1580. PubMed ID: 36843287
[TBL] [Abstract][Full Text] [Related]
8. Pierpont syndrome: report of a new patient.
Kahlert AK; Weidensee S; Mackenroth L; Porrmann J; Rump A; Di Donato N; Schröck E; Tzschach A
Clin Dysmorphol; 2017 Oct; 26(4):205-208. PubMed ID: 28562391
[TBL] [Abstract][Full Text] [Related]
9. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
[TBL] [Abstract][Full Text] [Related]
10. Pierpont syndrome due to mutation c.1337A>G in TBL1XR1 gene.
Tesarova M; Baxova A; Hansikova H; Lambert L; Vondrackova A; Leiska A; Zeman J
Clin Dysmorphol; 2022 Jul; 31(3):145-148. PubMed ID: 35165208
[No Abstract] [Full Text] [Related]
11. Nuclear corepressor and silencing mediator of retinoic and thyroid hormone receptors corepressor expression is incompatible with T(3)-dependent TRH regulation.
Becker N; Seugnet I; Guissouma H; Dupre SM; Demeneix BA
Endocrinology; 2001 Dec; 142(12):5321-31. PubMed ID: 11713232
[TBL] [Abstract][Full Text] [Related]
12. Very strong correlation between dominant negative activities of mutant thyroid hormone receptors and their binding avidity for corepressor SMRT.
Matsushita A; Misawa H; Andoh S; Natsume H; Nishiyama K; Sasaki S; Nakamura H
J Endocrinol; 2000 Dec; 167(3):493-503. PubMed ID: 11115777
[TBL] [Abstract][Full Text] [Related]
13. Increased homozygosity in the first Hispanic patient with plantar lipomatosis, unusual facies, and developmental delay (Pierpont syndrome): a case report.
O'Keefe S; Wefuan DT; Humberson JB; Schmidt K; Wiley J
J Med Case Rep; 2016 Aug; 10(1):223. PubMed ID: 27520388
[TBL] [Abstract][Full Text] [Related]
14. TBL1XR1 associated intellectual disability, a new missense variant with dysmorphic features plus autism: Expanding the phenotypic spectrum.
Arroyo Carrera I; Fernández-Burriel M; Lapunzina P; Tenorio JA; García Navas VD; Márquez Isidro E
Clin Genet; 2021 Jun; 99(6):812-817. PubMed ID: 33527360
[TBL] [Abstract][Full Text] [Related]
15. A heritable microduplication encompassing TBL1XR1 causes a genomic sister-disorder for the 3q26.32 microdeletion syndrome.
Riehmer V; Erger F; Herkenrath P; Seland S; Jackels M; Wiater A; Heller R; Beck BB; Netzer C
Am J Med Genet A; 2017 Aug; 173(8):2132-2138. PubMed ID: 28574232
[TBL] [Abstract][Full Text] [Related]
16. Plantar lipomatosis, unusual facies, and developmental delay: confirmation of Pierpont syndrome.
Oudesluijs GG; Hordijk R; Boon M; Sijens PE; Hennekam RC
Am J Med Genet A; 2005 Aug; 137(1):77-80. PubMed ID: 16007632
[TBL] [Abstract][Full Text] [Related]
17. The nuclear corepressors recognize distinct nuclear receptor complexes.
Cohen RN; Putney A; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2000 Jun; 14(6):900-14. PubMed ID: 10847591
[TBL] [Abstract][Full Text] [Related]
18. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor.
Makowski A; Brzostek S; Cohen RN; Hollenberg AN
Mol Endocrinol; 2003 Feb; 17(2):273-86. PubMed ID: 12554754
[TBL] [Abstract][Full Text] [Related]
19. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
[TBL] [Abstract][Full Text] [Related]
20. The nuclear corepressor, NCoR, regulates thyroid hormone action in vivo.
Astapova I; Lee LJ; Morales C; Tauber S; Bilban M; Hollenberg AN
Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19544-9. PubMed ID: 19052228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
